Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The corneal and conjunctival epithelial surfaces represent the outermost cellular layers of the eye, serving as the primary interface between the ocular environment and the external world. This anatomical structure functions as a robust physical and immunological barrier, protecting the eye from pathogens, debris, and desiccation while maintaining the transparency and refractive power of the cornea (StatPearls, 2023, NBK470338). The conjunctival epithelium is particularly notable for its goblet cells, which secrete mucins essential for tear film stability, whereas the corneal epithelium is highly specialized for optical clarity and rapid regeneration (PubMed, PMID: 28917533). In clinical practice, this surface is the site of action for numerous topical ophthalmic medications used to treat conditions like dry eye disease and inflammation. While not a single molecular target, the health of these epithelial layers is the primary focus of ocular surface therapeutics, which aim to reduce inflammation, enhance lubrication, and promote cellular repair (NIH/NEI, 2022).
Topical ophthalmic drugs interact with the ocular surface by modulating inflammatory pathways (e.g., T-cell inhibition via Cyclosporine), antagonizing integrins (e.g., Lifitegrast), or providing physical lubrication and osmoprotection to stabilize the tear film and promote epithelial healing.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corneal and conjunctival epithelial surface.